Ivologist review

What it is

Ivologist is a LegitScript-certified platform whose categories run across weight and metabolism, hormone therapy, hair regrowth, IV therapy, wellness and longevity, and supplements. It reports serving over 20,000 patients. Its sermorelin is described in its own copy as a synthetic peptide that stimulates the release of growth hormone from the pituitary gland, offered as an injectable; NAD⁺ is offered as an injectable too. It advertises nationwide service across all 50 states for its telehealth programs, while its in-person mobile IV service is location-dependent, with Texas, California, Ohio and Florida named. Its GLP-1 programs are priced by length — $279 for seven weeks, $399 for eleven, $899 for twenty-three.

How it works

A hybrid, and an honest one to describe as such. Telehealth programs handle weight, hormones and longevity nationally; a mobile IV service handles in-person administration in a limited set of metros. For an injectable product, having a clinician physically present is a materially different level of oversight from a vial arriving in the post, so the mobile arm is a real differentiator — but it is not available in most of the country, and NAD⁺ or sermorelin bought through the telehealth track is self-administered like anything else here. The commercial terms on the GLP-1 side are unusually clean and worth borrowing as questions for the peptide line: its own copy states no hidden fees, no monthly contracts, no insurance needed, no autodrafts and no memberships, and prices by program length rather than by dose. Against that sit the identity gaps. No legal entity name and no physical address are published anywhere on the site. No compounding pharmacy is named. And the entry mechanic has changed — a prior $70 consultation fee no longer appears, replaced by "Pay $25 deposit today to secure your provider consultation", with no statement of whether that $25 is credited against a program or is simply a fee.

Pricing transparency

Published for weight loss, absent for everything this board is about. Semaglutide programs are listed at $279 for seven weeks, $399 for eleven and $899 for twenty-three, with the site stating that the cost of medication is included and advertising a $33-a-week entry on a twelve-week plan. Those are weight-loss figures and say nothing about sermorelin or NAD⁺, neither of which carries a price anywhere on the site, so we are not quoting one. The structural lesson from the GLP-1 side is genuinely useful to carry into a peptide conversation: this provider sells fixed blocks with no membership and no autodraft, which is a materially better structure than an open-ended subscription if you want to try something and stop. Ask whether the peptide and NAD⁺ lines are sold the same way — as a fixed block with medication included, or as a rolling charge — what a month or a course costs, whether the $25 deposit is credited, and whether the no-contract, no-autodraft terms apply outside the weight-loss programs.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Ivologist carries LegitScript certification, which is a check on legal and regulatory operation rather than on whether a product works, and it names no compounding pharmacy — compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, the site's own description of sermorelin is accurate as far as it goes: it does stimulate growth-hormone release from the pituitary, and that is a real, well-described mechanism. What the description omits is that mechanism is where the evidence stops. No controlled human trial shows compounded sermorelin delivers the body-composition, recovery or anti-aging outcomes the category is sold on, and the long-term human data stays thin. Injected NAD⁺ is weaker still — no controlled human outcome trials at all, with the single human intravenous study a pharmacokinetic pilot finding that infused NAD⁺ clears from plasma quickly. The NAD⁺ forms with human trial data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker rather than a demonstrated clinical benefit. Individual results vary.

Pros and watch-outs

The evidence behind what Ivologist prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

How Ivologist compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Invigor Medical

  Prescription at-home NAD⁺ injections via telehealth

  See Invigor Medical →
• SLSystem Labs

  NAD⁺ bundled with glutathione, B-12 and sermorelin from one service

  See System Labs →
• Live Vital

  Pairing a GLP-1 with a wider peptide and longevity protocol

  See Live Vital →